A dynamic cycle of O-linked N-acetylglucosamine (O-GlcNAc) addition and removal acts on nuclear pore proteins, transcription factors, and kinases to modulate cellular signaling cascades. Two highly conserved enzymes (O-GlcNAc transferase and O-GlcNAcase) catalyze the final steps in this nutrient-driven ''hexosamine-signaling pathway.'' A single nucleotide polymorphism in the human O-GlcNAcase gene is linked to type 2 diabetes. Here, we show that Caenorhabditis elegans oga-1 encodes an active O-GlcNAcase. We also describe a knockout allele, oga-1(ok1207), that is viable and fertile yet accumulates OGlcNAc on nuclear pores and other cellular proteins. Interfering with O-GlcNAc cycling with either oga-1(ok1207) or the O-GlcNAc transferase-null ogt-1(ok430) altered Ser-and Thr-phosphoprotein profiles and increased glycogen synthase kinase 3 (GSK-3) levels. Both the oga-1(ok1207) and ogt-1(ok430) strains showed elevated stores of glycogen and trehalose, and decreased lipid storage. These striking metabolic changes prompted us to examine the insulin-like signaling pathway controlling nutrient storage, longevity, and dauer formation in the C. elegans O-GlcNAc cycling mutants. Indeed, we found that the oga-1(ok1207) knockout augmented dauer formation induced by a temperature sensitive insulin-like receptor (daf-2) mutant under conditions in which the ogt-1(ok430)-null diminished dauer formation. Our findings suggest that the enzymes of O-GlcNAc cycling ''finetune'' insulin-like signaling in response to nutrient flux. The knockout of O-GlcNAcase (oga-1) in C. elegans mimics many of the metabolic and signaling changes associated with human insulin resistance and provides a genetically amenable model of non-insulin-dependent diabetes.hexosamine ͉ insulin signaling ͉ nutrients ͉ obesity O -linked N-acetylglucosamine (O-GlcNAc) is a dynamic modification of nuclear pore complexes, transcription complexes, and kinases (1-4). Because of the diverse targets modified by O-GlcNAc, deciphering its role in cell physiology has proven challenging. Two enzymes regulate the cycling of O-GlcNAc: the O-linked GlcNAc transferase (OGT) and the glycosidase, OGlcNAcase (OGA) (1-4). In mammals, the two enzymes of OGlcNAc cycling are products of single genes; alternative splicing produces isoforms differing in subcellular location and substrate specificity (1,(5)(6)(7)(8)(9). The O-GlcNAc cycling enzymes act like kinases and phosphatases to modify Ser and Thr residues of target proteins. In addition, the hexosamine biosynthetic pathway giving rise to the O-GlcNAc donor, UDP-GlcNAc, is highly regulated and responsive to nutrient availability (4,(10)(11)(12)(13)(14).OGA, originally identified as a meningioma auto antigen and termed MGEA5 (8), is a member of the family 84 glycoside hydrolase {Carbohydrate-Active Enzymes [CAZy] database [GH 84 (caz, a)]}. OGA is highly conserved in eukaryotic evolution from Drosophila melanogaster and Caenorhabditis elegans to rodents and man. In mammals, the MGEA5 gene produces at least two isoforms differing ...